NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions

NSD3 in Cancer: Unraveling Methyltransferase-Dependent and Isoform-Specific Functions

NSD3 (nuclear receptor-binding SET domain protein 3) is a member of the NSD histone methyltransferase family of proteins. In recent years, it has been identified as a potential oncogene in certain types of cancer. The NSD3 gene encodes three isoforms, the long version (NSD3L), a short version (NSD3S...

Full description

Bibliographic Details
Main Authors:	Yanara Nuñez, Sebastian Vera, Victor Baeza, Valentina Gonzalez-Pecchi
Format:	Article
Language:	English
Published:	MDPI AG 2024-01-01
Series:	International Journal of Molecular Sciences
Subjects:	cancer molecular oncology oncogenes NSD3 NSD3S
Online Access:	https://www.mdpi.com/1422-0067/25/2/944

Similar Items

NSD1: A Lysine Methyltransferase between Developmental Disorders and Cancer
by: Samantha Tauchmann, et al.
Published: (2021-08-01)

Structure, Activity and Function of the NSD3 Protein Lysine Methyltransferase
by: Philipp Rathert
Published: (2021-07-01)

Prospect of targeting lysine methyltransferase NSD3 for tumor therapy
by: Dan Li, et al.
Published: (2023-08-01)

Alternatively Splicing Interactomes Identify Novel Isoform-Specific Partners for NSD2
by: Weidi Wang, et al.
Published: (2021-02-01)

The first pineoblastoma case report of a patient with Sotos syndrome harboring NSD1 germline mutation
by: Xizan Yue, et al.
Published: (2024-03-01)

Penentuan Koefisien Hidraulik pada Tapak NSD, Serpong, Berdasarkan Metoda Uji Permeabilitas In-Situ
by: Heri Syaeful, et al.
Published: (2013-05-01)

Structural and functional specificity of H3K36 methylation
by: Ulysses Tsz Fung Lam, et al.
Published: (2022-05-01)

NSD1 gene evolves under episodic selection within primates and mutations of specific exons in humans cause Sotos syndrome
by: Vanessa I. Romero, et al.
Published: (2022-12-01)

NSD1 in erythroid differentiation and leukemogenesis
by: Samantha Tauchmann, et al.
Published: (2020-11-01)

Investigation of NSD2 Protein Expression Changes in Hepatocellular Carcinoma Cells After Treatment With Curcumin and Phthalates
by: Seyed Ehsan Alavian, et al.
Published: (2023-01-01)

Investigation of NSD2 Protein Expression Changes in Hepatocellular Carcinoma Cells After Treatment With Curcumin and Phthalates
by: Seyed Ehsan Alavian, et al.
Published: (2023-09-01)

METTL3 enhances NSD2 mRNA stability to reduce renal impairment and interstitial fibrosis in mice with diabetic nephropathy
by: Weiming Tang, et al.
Published: (2022-03-01)

NSD2 as a Promising Target in Hematological Disorders
by: Alba Azagra, et al.
Published: (2022-09-01)

A Novel Missense Mutation of the NSD1 Gene Associated with Overgrowth in Three Generations of an Italian Family: Case Report, Differential Diagnosis, and Review of Mutations of NSD1 Gene in Familial Sotos Syndrome
by: Gianluigi Laccetta, et al.
Published: (2017-11-01)

A novel nonsense variant in NSD1 gene in a female child with Sotos syndrome: A case report and literature review
by: Xinting Liu, et al.
Published: (2023-12-01)

Understanding the Roles of the NSD Protein Methyltransferases in Head and Neck Squamous Cell Carcinoma
by: Madhavi Murali, et al.
Published: (2022-11-01)

Overexpression of EZH2/NSD2 Histone Methyltransferase Axis Predicts Poor Prognosis and Accelerates Tumor Progression in Triple-Negative Breast Cancer
by: Bo Gao, et al.
Published: (2021-02-01)

De novo truncating variant in NSD2gene leading to atypical Wolf-Hirschhorn syndrome phenotype
by: Yanrui Jiang, et al.
Published: (2019-08-01)

Clinical details of individuals with Rauch–Steindl syndrome due to NSD2 truncating variants
by: Eriko Nishi, et al.
Published: (2024-02-01)

Idea Generation for New Service Development (NSD): Harnessing the Power of Social Media Platforms
by: Neeraj Pandeya, et al.
Published: (2022-02-01)

NSD2 Promotes Renal Cancer Progression Through Stimulating Akt/Erk Signaling
by: Han X, et al.
Published: (2020-01-01)

H3K36 methyltransferase NSD1 is essential for normal B1 and B2 cell development and germinal center formation
by: Sulan Zhai, et al.
Published: (2022-11-01)

Clinical and Biological Characteristics of 14 Adult Cases of NUP98-NSD1+ Acute Myeloid Leukemia
by: Yan-jun Sun, et al.
Published: (2023-12-01)

In silico derived small molecules targeting the finger-finger interaction between the histone lysine methyltransferase NSD1 and Nizp1 repressor
by: Andrea Berardi, et al.
Published: (2020-01-01)

Posttranslational modification of Aurora A‐NSD2 loop contributes to drug resistance in t(4;14) multiple myeloma
by: Hongmei Jiang, et al.
Published: (2022-04-01)

Melatonin enhances osteoblastogenesis of senescent bone marrow stromal cells through NSD2‐mediated chromatin remodelling
by: Ying Xie, et al.
Published: (2022-02-01)

NSD family proteins: Rising stars as therapeutic targets
by: Lin He, et al.
Published: (2024-04-01)

RNA Analysis and Clinical Characterization of a Novel Splice Variant in the NSD1 Gene Causing Familial Sotos Syndrome
by: Olatz Villate, et al.
Published: (2022-02-01)

NSD Overexpression in the Fat Body Increases Antimicrobial Peptide Production by the Immune Deficiency Pathway in <i>Drosophila</i>
by: Chihyun Won, et al.
Published: (2023-05-01)

Molecular Analysis and Reclassification of NSD1 Gene Variants in a Cohort of Patients with Clinical Suspicion of Sotos Syndrome
by: Barbara Testa, et al.
Published: (2023-01-01)

Effective Factors of Customer Involvement in the Launching of New Services in Banking Systems
by: Mohammad Meigounpoory, et al.
Published: (2014-11-01)

Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia
by: Sagarajit Mohanty, et al.
Published: (2020-09-01)

NSD2 E1099K drives relapse in pediatric acute lymphoblastic leukemia by disrupting 3D chromatin organization
by: Sonali Narang, et al.
Published: (2023-04-01)

Loss of NSD2 causes dysregulation of synaptic genes and altered H3K36 dimethylation in mice
by: Shiori Kinoshita, et al.
Published: (2024-02-01)

Long non-coding RNAs MACC1-AS1 and FOXD2-AS1 mediate NSD2-induced cisplatin resistance in esophageal squamous cell carcinoma
by: Wenhua Xue, et al.
Published: (2021-03-01)

Difference-based M-estimator of generalized semiparametric model with NSD errors
by: Fangning Fu, et al.
Published: (2019-03-01)

NSD3, a member of nuclear receptor‐binding SET domain family, is a potential prognostic biomarker for pancreatic cancer
by: Qunli Xiong, et al.
Published: (2023-05-01)

SMARCA5 interacts with NUP98-NSD1 oncofusion protein and sustains hematopoietic cells transformation
by: Zivojin Jevtic, et al.
Published: (2022-01-01)

Incidentalome in Neurogenetics: Pathogenic Variant of NSD1 in a Patient With Spinocerebellar Ataxia (SCA)
by: Harvy Velasco, et al.
Published: (2018-03-01)

Novel dual-targeting inhibitors of NSD2 and HDAC2 for the treatment of liver cancer: structure-based virtual screening, molecular dynamics simulation, and in vitro and in vivo biological activity evaluations
by: Xing Jin, et al.
Published: (2024-12-01)